Earnings Call · Q2 FY2023·2023-08-07

Q2 23EPS +12.12%·Rev n/aQ1 23EPS +3.13%·Rev n/aQ4 22EPS +6.06%·Rev n/aQ3 22EPS +18.75%·Rev n/a⚠ consensus missing

CAPRICOR THERAPEUTICS, INC. CAPR

AJ Bergmann — CFO

Linda Marban — CEO

+3.1%1d on move date+2.2% vs SPY3d+29.1%5d+32.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAPR calls or request research access.

More CAPR calls Browse calls Request research access